19 June 2013
Keywords: lisofylline, ph, iii, 2nd, qtr, says, cti
Article | 19 September 1994
Cell Therapeutics Inc should be in a position to start Phase III trials
of its lead product, lisofylline, by the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 1994
26 September 1994
18 June 2013
© 2013 thepharmaletter.com